Peer-influenced content. Sources you trust. No registration required. This is HCN.
DentistryIQ
As the FDA approves the first over-the-counter oral contraceptive, dental professionals must be cognizant of potential impacts on oral health and patient management.
Dentistry July 17th 2023
Dentistry Today
Discover how Overjet’s AI technology, with its fourth FDA clearance, is setting new standards in the dental industry, enhancing caries detection and treatment planning for patients aged 12 and older.
Cath Lab Digest
The FDA-approved LODOCO is anticipated to significantly advance cardiovascular treatment, reducing cardiac events by 31% in established cardiovascular disease patients. Read about the innovative research that has led to this breakthrough in patient care.
Cardiology July 12th 2023
Medical Professionals Reference (MPR)
Explore how the newly FDA-cleared iLet Bionic Pancreas, integrating the iLet ACE Pump and the iLet Dosing Decision Software, could reshape the landscape of type 1 diabetes management through its adaptive and autonomous insulin dosing capabilities.
Endocrinology, Diabetes, Metabolism July 6th 2023
Psych Congress Network
Discover how the FDA’s first draft guidance on psychedelic drugs outlines a path for future medical treatments, addressing crucial considerations from study design to safety measures. Learn more about how this pivotal step could transform the therapeutic landscape.
Psychiatry July 5th 2023
Neurology Advisor
Accelerate your understanding of thrombotic disease treatment developments; delve into the Fast Track designation of milvexian, a promising oral factor XIa inhibitor.
Cardiology June 28th 2023